Slate Business Slate Podcasts

On today’s episode of Hear Me Out: get back to work.

When your job becomes obsolete, is it the government’s job to teach you to do something else? 

That’s the theory behind federal workforce training programs – which have existed, in various forms, for a long time. The problem is that studies are starting to show that these programs don’t provide much of an edge to workers… and that the jobs they place for might not be good jobs.

Kevin Carey of New America joins us to argue for a retooling of federal work training.


If you have thoughts you want to share, or an idea for a topic we should tackle, you can email the show: hearmeout@slate.com

Podcast production by Maura Currie.

Want more Hear Me Out? Subscribe to Slate Plus to access ad-free listening across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Or, visit slate.com/hearmeoutplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The story of IUDs is a story of technology, reproductive rights, shortcomings in communication about women’s health, and politics. 

Guest: Mia Armstrong-Lopez, managing editor at ASU Media Enterprise and author of a recent piece on IUDs for Slate. 

Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, Slate Money goes to court. Felix Salmon, Emily Peck, and Elizabeth Spiers discuss two big Supreme Court rulings: One that stripped government agencies of regulatory power, and another that struck down Purdue Pharma and the Sacklers’ bankruptcy plan. Also: Giant “megacap” companies rule the stock market. Is that good? In the Plus segment: the once-popular potato has fallen out of fashion, but the hosts make the case for a spud renaissance.
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get an ad-free experience across the network and an additional segment of our regular show every week. You’ll also be supporting the work we do here on Slate Money. Sign up now at slate.com/moneyplus to help support our work.
Podcast production by Jared Downing and Cheyna Roth.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Saying any one storm or heat wave or weather in general was “caused by climate change” is tricky—summer is, after all, usually pretty hot, and storms happen. But researchers are working on a model that brings “climate change” from abstract into the particular.  

Guest: Daniel Swain, climate scientist at the UCLA Institute of the Environment and Sustainability, studying how extreme events are changing on a warming Earth.

Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

For years, psychiatrists have been researching new methods to help people with treatment-resistant mental illness. These include severe cases of depression, post-traumatic stress disorder, and other debilitating diagnoses.
One type of drug has seen some positive results in clinical trials: psychedelics like psilocybin, MDMA, ketamine, and LSD.
In professional medical settings, they’re used as a part of a multifaceted approach to mental health treatment, including supervised therapy sessions while a patient is on a drug.
Recently the pharmaceutical manufacturer Lykos petitioned the FDA to approve the psychedelic MDMA as a part of caring for treatment-resistant PTSD.
Earlier this month, an advisory committee to the FDA released their vote of rejecting to approve the drug. 
Now it’s up to the FDA to make the final call, but the odds are not in the favor of Lykos and many psychiatrists and patients who’ve seen positive outcomes as a result of these MDMA-assisted trials.
Psychiatrist and entrepreneur Dave Rabin is one of the doctors pushing to approve psychedelic-assisted therapy. 
On this week’s episode of Well, Now we ask him about the results of his trials using psychedelics in therapy as well as what he thinks the future holds for this field as we wait for the FDA’s final verdict.
If you liked this episode, check out: “As Little Regulation As Guns”: How Social Media Hurts Youth Mental Health
Well, Now is hosted by Dr. Kavita Patel and registered dietitian nutritionist Maya Feller.
Editing and podcast production by Vic Whitley-Berry, with support this week from Kristie Taiwo-Makanjuola.
Editorial oversight from Alicia Montgomery, Vice President of Slate Audio.
Send your comments and recommendations on what to cover to wellnow@slate.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices

How To!’s senior editor Joel Meyer recently experienced a yard sale fail and wants to know what went wrong. He spent hours planning and organizing the items on his lawn, but when it was all said and done he barely made enough to cover the cost of lunch. Enter this week’s expert, Ava Seavey, a self-described master of garage-sale-ology and author of Ava’s Guide to Garage Sale Gold. Seavey tells host Courtney Martin some hilarious stories and insider tips for how to cash in on all your old stuff.

If you liked this episode, check out “How To Find the Gems in All Your Junk”

Do you have a problem that needs solving? Send us a note at howto@slate.com or leave us a voicemail at 646-495-4001 and we might have you on the show. Subscribe for free on Apple, Spotify or wherever you listen.

Podcast production by Derek John, Joel Meyer, Rosemary Belson, and Kevin Bendis.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now at slate.com/howtoplus.
Learn more about your ad choices. Visit megaphone.fm/adchoices